Platinum folate nanoparticles toxicity: Cancer vs. normal cells

Toxicology in Vitro

Volumn 27, Issue 2, 2013, Pages 882-889

  Mironava, Tatsiana ^a   Simon, Marcia ^a   Rafailovich, Miriam H ^b   Rigas, Basil ^a  

^a STONY BROOK UNIVERSITY   (United States)

^b Stony Brook University   (United States)

Author keywords

Cancer; Folic acid receptors; Platinum folate nanoparticles; Targeted drug delivery

Indexed keywords

FOLATE RECEPTOR; FOLIC ACID; PLATINUM FOLATE NANOPARTICLE; PLATINUM NANOPARTICLE; UNCLASSIFIED DRUG;

AGED; ARTICLE; BREAST CANCER; CANCER CELL; CELL STRUCTURE; CELL VACUOLE; CHEMICAL STRUCTURE; CONTROLLED STUDY; CYTOTOXICITY; ENDOCYTOSIS; FEMALE; HUMAN; HUMAN CELL; IC 50; KERATINOCYTE; PARTICLE SIZE; TARGET CELL;

APOPTOSIS; CELL LINE, TUMOR; CELL SURVIVAL; CELLS, CULTURED; FOLIC ACID; HUMANS; KERATINOCYTES; METAL NANOPARTICLES; MICROSCOPY, ELECTRON, TRANSMISSION; NECROSIS; NEOPLASMS; PLATINUM;

EID: 84873153712     PISSN: 08872333     EISSN: 18793177     Source Type: Journal    
DOI: 10.1016/j.tiv.2013.01.005     Document Type: Article

References (48)

1. Arvizo R.R., Bhattacharyya S., Kudgus R.A., Giri K., Bhattacharya R., Mukherjee P. Intrinsic therapeutic applications of noble metal nanoparticles: past, present and future. Chemical Society Reviews 2012, 41:2943-2970.
2. Basal E., Eghbali-Fatourechi G.Z., Kalli K.R., Hartmann L.C., Goodman K.M., Goode E.L., Kamen B.A., Low P.S., Knutson K.L. Functional folate receptor alpha is elevated in the blood of ovarian cancer patients. PLoS ONE 2009, 4.
3. Bellah M.M., Christensen S., Iqbal S.M. Nanostructures for medical diagnostics. Journal of Nanomaterials 2012.
4. Bhattacharyya S., Gonzalez M., Robertson J.D., Bhattacharya R., Mukherjee P. A simple synthesis of a targeted drug delivery system with enhanced cytotoxicity. Chemical Communications 2011, 47:8530-8532.
5. Chen J., Li S., Shen Q., He H., Zhang Y. Enhanced cellular uptake of folic acid-conjugated PLGA-PEG nanoparticles loaded with vincristine sulfate in human breast cancer. Drug Development and Industrial Pharmacy 2011, 37:1339-1346.
6. Davis R.E., Nicol D.J. Folic-Acid. International Journal of Biochemistry 1988, 20:133-139.
7. Elliott A.M., Shetty A.M., Wang J., Hazle J.D., Stafford R.J. Use of gold nanoshells to constrain and enhance laser thermal therapy of metastatic liver tumours. International Journal of Hyperthermia 2010, 26:434-440.
8. Elnakat H., Ratnam M. Distribution, functionality and gene regulation of folate receptor isoforms: implications in targeted therapy. Advanced drug delivery reviews 2004, 56:1067-1084.
9. Elsherbini A.A.M., Saber M., Aggag M., El-Shahawy A., Shokier H.A.A. Laser and radiofrequency-induced hyperthermia treatment via gold-coated magnetic nanocomposites. International Journal of Nanomedicine 2011, 6:2155-2165.
10. Freese C., Uboldi C., Gibson M.I., Unger R.E., Weksler B.B., Romero I.A., Couraud P.O., Kirkpatrick C.J. Uptake and cytotoxicity of citrate-coated gold nanospheres: Comparative studies on human endothelial and epithelial cells. Particle and Fibre Toxicology 2012, 9.
11. Gao Z.B., Zhang L.N., Sun Y.J. Nanotechnology applied to overcome tumor drug resistance. Journal of Controlled Release 2012, 162:45-55.
12. Ghosh J., Das J., Manna P., Sil P.C. Taurine prevents arsenic-induced cardiac oxidative stress and apoptotic damage: role of NF-kappa B, p38 and JNK MAPK pathway. Toxicology and Applied Pharmacology 2009, 240:73-87.
13. Glazer E.S., Curley S.A. Radiofrequency field-induced thermal cytotoxicity in cancer cells treated with fluorescent nanoparticles. Cancer 2010, 116:3285-3293.
14. Govender P., Therrien B., Smith G.S. Bio-metallodendrimers - emerging strategies in metal-based drug design. European Journal of Inorganic Chemistry 2012, 2853-2862.
15. Greulich C., Diendorf J., Gessmann J., Simon T., Habijan T., Eggeler G., Schildhauer T.A., Epple M., Koller M. Cell type-specific responses of peripheral blood mononuclear cells to silver nanoparticles. Acta biomaterialia 2011, 7:3505-3514.
16. Hanley C., Thurber A., Hanna C., Punnoose A., Zhang J.H., Wingett D.G. The influences of cell type and zno nanoparticle size on immune cell cytotoxicity and cytokine induction. Nanoscale Research Letters 2009, 4:1409-1420.
17. Huang P., Bao L., Zhang C., Lin J., Luo T., Yang D., He M., Li Z., Gao G., Gao B., Fu S., Cui D. Folic acid-conjugated silica-modified gold nanorods for X-ray/CT imaging-guided dual-mode radiation and photo-thermal therapy. Biomaterials 2011, 32:9796-9809.
18. Ji Z., Lin G., Lu Q., Meng L., Shen X., Dong L., Fu C., Zhang X. Targeted therapy of SMMC-7721 liver cancer in vitro and in vivo with carbon nanotubes based drug delivery system. Journal of colloid and interface science 2012, 365:143-149.
19. Kalli K.R., Oberg A.L., Keeney G.L., Christianson T.J.H., Low P.S., Knutson K.L., Hartmann L.C. Folate receptor alpha as a tumor target in epithelial ovarian cancer. Gynecologic Oncology 2008, 108:619-626.
20. Kularatne S.A., Low P.S. Targeting of nanoparticles: folate receptor. Methods in molecular biology 2010, 624:249-265. (Clifton, NJ).
21. Liang C., Yang Y., Ling Y., Huang Y., Li T., Li X. Improved therapeutic effect of folate-decorated PLGA-PEG nanoparticles for endometrial carcinoma. Bioorganic & Medicinal Chemistry 2011, 19:4057-4066.
22. Low P.S., Antony A.C. Folate receptor-targeted drugs for cancer and inflammatory diseases - preface. Advanced drug delivery reviews 2004, 56:1055-1058.
23. Low P.S., Henne W.A., Doorneweerd D.D. Discovery and development of folic-acid-based receptor targeting for Imaging and therapy of cancer and inflammatory diseases. Accounts of Chemical Research 2008, 41:120-129.
24. Lu Y.-J., Wei K.-C., Ma C.-C.M., Yang S.-Y., Chen J.-P. Dual targeted delivery of doxorubicin to cancer cells using folate-conjugated magnetic multi-walled carbon nanotubes. Colloids and surfaces. B, Biointerfaces 2012, 89:1-9.
25. Mattson M.P., Keller J.N., Begley J.G. Evidence for synaptic apoptosis. Experimental Neurology 1998, 153:35-48.
26. Mironava T., Hadjiargyrou M., Simon M., Jurukovski V., Rafailovich M.H. Gold nanoparticles cellular toxicity and recovery: Effect of size, concentration and exposure time. Nanotoxicology 2010, 4:120-137.
27. Mishra G., Hazari P.P., Kumar N., Mishra A.K. In vitro and in vivo evaluation of (99m) Tc-DO3A-EA-Folate for receptor-mediated targeting of folate positive tumors. Journal of Drug Targeting 2011, 19:761-769.
28. Pan Y., Neuss S., Leifert A., Fischler M., Wen F., Simon U., Schmid G., Brandau W., Jahnen-Dechent W. Size-dependent cytotoxicity of gold nanoparticles. Small 2007, 3:1941-1949. (Weinheim an der Bergstrasse, Germany).
29. Porcel E., Liehn S., Remita H., Usami N., Kobayashi K., Furusawa Y., Le Sech C., Lacombe S. Platinum nanoparticles: a promising material for future cancer therapy?. Nanotechnology 2010, 21.
30. Reddy P.R., Varaprasad K., Reddy N.N., Raju K.M., Reddy N.S. Fabrication of Au and Ag Bi-metallic nanocomposite for antimicrobial applications. Journal of Applied Polymer Science 2012, 125:1357-1362.
31. Rheinwald J.G., Beckett M.A. Tumorigenic keratinocyte lines requiring ancorage and fibroblasts support cultured from human squamous-cell carcinomas. Cancer Research 1981, 41:1657-1663.
32. Ross J.F., Chaudhuri P.K., Ratnam M. Differential regulation of folate receptor isoforms in normal and malignant tissues in vivo and in established cell lines - physiological and clinical implications. Cancer 1994, 73:2432-2443.
33. Salazar M.D.A., Ratnam M. The folate receptor: what does it promise in tissue-targeted therapeutics?. Cancer and Metastasis Reviews 2007, 26:141-152.
34. Sanna V., Sechi M. Nanoparticle therapeutics for prostate cancer treatment. Nanomedicine-Nanotechnology Biology and Medicine 2012, 8:S31-S36.
35. Shmeeda H., Mak L., Tzemach D., Astrahan P., Tarshish M., Gabizon A. Intracellular uptake and intracavitary targeting of folate-conjugated liposomes in a mouse lymphoma model with up-regulated folate receptors. Molecular Cancer Therapeutics 2006, 5:818-824.
36. Sohaebuddin S.K., Thevenot P.T., Baker D., Eaton J.W., Tang L.P. Nanomaterial cytotoxicity is composition, size, and cell type dependent. Particle and Fibre Toxicology 2010, 7.
37. Sun Y., Frenkel A.I., White H., Zhang L.H., Zhu Y.M., Xu H.P., Yang J.C., Koga T., Zaitsev V., Rafailovich M.H., Sokolov J.C. Comparison of decanethiolate gold nanoparticles synthesized by one-phase and two-phase methods. Journal of Physical Chemistry B 2006, 110:23022-23030.
38. Teow Y., Valiyaveettil S. Active targeting of cancer cells using folic acid-conjugated platinum nanoparticles. Nanoscale 2010, 2:2607-2613.
39. Tran T., Shatnawi A., Zheng X., Kelley K.M.M., Ratnam M. Enhancement of folate receptor alpha expression in tumor cells through the glucocorticoid receptor: a promising means to improved tumor detection and targeting. Cancer Research 2005, 65:4431-4441.
40. Vaitilingam B., Chelvam V., Kularatne S.A., Poh S., Ayala-Lopez W., Low P.S. A folate receptor-alpha-specific ligand that targets cancer tissue and not sites of inflammation. Journal of Nuclear Medicine 2012, 53:1127-1134.
41. Vanlangenakker N., Vanden Berghe T., Krysko D.V., Festjens N., Vandenabeele P. Molecular mechanisms and pathophysiology of necrotic cell death. Current Molecular Medicine 2008, 8:207-220.
42. Veerasamy R., Xin T.Z., Gunasagaran S., Xiang T.F.W., Yang E.F.C., Jeyakumar N., Dhanaraj S.A. Biosynthesis of silver nanoparticles using mangosteen leaf extract and evaluation of their antimicrobial activities. Journal of Saudi Chemical Society 2011, 15:113-120.
43. Vlahov I.R., Leamon C.P. Engineering folate-drug conjugates to target cancer: from chemistry to clinic. Bioconjugate Chemistry 2012, 23:1357-1369.
44. Wang C.U., Arai Y., Kim I., Jang W., Lee S., Hafner J.H., Jeoung E., Jung D., Kwon Y. Surface-modified gold nanorods for specific cell targeting. Journal of the Korean Physical Society 2012, 60:1700-1707.
45. Werner M.E., Karve S., Sukumar R., Cummings N.D., Copp J.A., Chen R.C., Zhang T., Wang A.Z. Folate-targeted nanoparticle delivery of chemo- and radiotherapeutics for the treatment of ovarian cancer peritoneal metastasis. Biomaterials 2011, 32:8548-8554.
46. Xu Z.H., Jin J.F., Siu L.K.S., Yao H., Sze J., Sun H.Z., Kung H.F., Poon W.S., Ng S.S.M., Lin M.C. Folic acid conjugated mPEG-PEI600 as an efficient non-viral vector for targeted nucleic acid delivery. International Journal of Pharmaceutics 2012, 426:182-192.
47. Yang F., Jin C., Subedi S., Lee C.L., Wang Q., Jiang Y.J., Li J., Di Y., Fu D.L. Emerging inorganic nanomaterials for pancreatic cancer diagnosis and treatment. Cancer Treatment Reviews 2012, 38:566-579.
48. Zhang S.W., Nelson A., Beales P.A. Freezing or wrapping: the role of particle size in the mechanism of nanoparticle-biomembrane interaction. Langmuir 2012, 28:12831-12837.